Embryonic signaling pathways and rhabdomyosarcoma: Contributions to cancer development and opportunities for therapeutic targeting

Sarcoma

Volumn 2012, Issue , 2012, Pages

  Belyea, Brian ^a,b   Kephart, Julie Grondin ^a   Blum, Jordan ^a   Kirsch, David G ^a   Linardic, Corinne M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 2 (3 CHLORO 4 HYDROXYANILINO) 3 (2 NITROPHENYL)MALEIMIDE; ERISMODEGIB; GDC 0049; INDIRUBIN; IPI 296; JAGGED1; MK 0752; MONOCLONAL ANTIBODY; N (6,7 DIHYDRO 6 OXO 5H DIBENZ[B,D]AZEPIN 7 YL) 2,2 DIMETHYL N' (2,2,3,3,3 PENTAFLUOROPROPYL)PROPANEDIAMIDE; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; OTSA101; PROTEIN INHIBITOR; UNCLASSIFIED DRUG; VISMODEGIB; WNT PROTEIN;

ACUTE LYMPHOCYTIC LEUKEMIA; ASTROCYTOMA; CARCINOGENESIS; CENTRAL NERVOUS SYSTEM TUMOR; CHONDROSARCOMA; DRUG MECHANISM; EMBRYONIC SIGNALING PATHWAY; GLIOMA; HEPATOBLASTOMA; HUMAN; LYMPHOMA; MEDULLOBLASTOMA; MUSCLE DEVELOPMENT; NEUROBLASTOMA; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; REVIEW; RHABDOMYOSARCOMA; SARCOMA; SIGNAL TRANSDUCTION; SOLID TUMOR; SYNOVIAL SARCOMA; T CELL LEUKEMIA; WNT SIGNALING PATHWAY;

EID: 84861014887     PISSN: 1357714X     EISSN: 13691643     Source Type: Journal    
DOI: 10.1155/2012/406239     Document Type: Review

References (94)

1. Huh W. W., Skapek S. X., Childhood rhabdomyosarcoma: new insight on biology and treatment Current Oncology Reports 2010 12 6 402 410
2. Saab R., Spunt S. L., Skapek S. X., Myogenesis and rhabdomyosarcoma: the jekyll and hyde of skeletal muscle Current Topics in Developmental Biology 2011 94 C 197 234
3. Linardic C. M., PAX3-FOXO1 fusion gene in rhabdomyosarcoma Cancer Letters 2008 270 1 10 18
4. Davicioni E., Anderson M. J., Finckenstein F. G., Lynch J. C., Qualman S. J., Shimada H., Schofield D. E., Buckley J. D., Meyer W. H., Sorensen P. H. B., Triche T. J., Molecular classification of rhabdomyosarcomagenotypic and phenotypic determinants of diagnosis: a report from the Children's Oncology Group American Journal of Pathology 2009 174 2 550 564
5. Meza J. L., Anderson J., Pappo A. S., Meyer W. H., Analysis of prognostic factors in patients with nonmetastatic rhabdomyosarcoma treated on intergroup rhabdomyosarcoma studies III and IV: the children's oncology group Journal of Clinical Oncology 2006 24 24 3844 3851 (Pubitemid 46630730)
6. Arndt C. A. S., Stoner J. A., Hawkins D. S., Rodeberg D. A., Hayes-Jordan A. A., Paidas C. N., Parham D. M., Teot L. A., Wharam M. D., Breneman J. C., Donaldson S. S., Anderson J. R., Meyer W. H., Vincristine, actinomycin, and cyclophosphamide compared with vincristine, actinomycin, and cyclophosphamide alternating with vincristine, topotecan, and cyclophosphamide for intermediate-risk rhabdomyosarcoma: Children's Oncology Group Study D9803 Journal of Clinical Oncology 2009 27 31 5182 5188
7. Oberlin O., Rey A., Lyden E., Bisogno G., Stevens M. C. G., Meyer W. H., Carli M., Anderson J. R., Prognostic factors in metastatic rhabdomyosarcomas: results of a pooled analysis from United States and European Cooperative Groups Journal of Clinical Oncology 2008 26 14 2384 2389
8. Breneman J. C., Lyden E., Pappo A. S., Link M. P., Anderson J. R., Parham D. M., Qualman S. J., Wharam M. D., Donaldson S. S., Maurer H. M., Meyer W. H., Baker K. S., Paidas C. N., Crist W. M., Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcomaa report from the Intergroup Rhabdomyosarcoma Study IV Journal of Clinical Oncology 2003 21 1 78 84
9. Carli M., Colombatti R., Oberlin O., Bisogno G., Treuner J., Koscielniak E., Tridello G., Garaventa A., Pinkerton R., Stevens M., European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors Journal of Clinical Oncology 2004 22 23 4735 4742 (Pubitemid 41185090)
10. Pappo A. S., Anderson J. R., Crist W. M., Wharam M. D., Breitfeld P. P., Hawkins D., Raney R. B., Womer R. B., Parham D. M., Qualman S. J., Grier H. E., Survival after relapse in children and adolescents with rhabdomyosarcoma: a report from the intergroup rhabdomyosarcoma study group Journal of Clinical Oncology 1999 17 11 3487 3493 (Pubitemid 29517919)
11. Tiffin N., Williams R. D., Shipley J., Pritchard-Jones K., PAX7 expression in embryonal rhabdomyosarcoma suggests an origin in muscle satellite cells British Journal of Cancer 2003 89 2 327 332 (Pubitemid 36976324)
12. Hettmer S., Wagers A. J., Muscling in: uncovering the origins of rhabdomyosarcoma Nature Medicine 2010 16 2 171 173
13. Keller C., Arenkiel B. R., Coffin C. M., El-Bardeesy N., DePinho R. A., Capecchi M. R., Alveolar rhabdomyosarcomas in conditional Pax3:Fkhr mice: cooperativity of Ink4a/ARF and Trp53 loss of function Genes and Development 2004 18 21 2614 2626 (Pubitemid 39453101)
14. Murphy M., Kardon G., Origin of vertebrate limb muscle: the role of progenitor and myoblast populations Current Topics in Developmental Biology 2011 96 1 32
15. Bryson-Richardson R. J., Currie P. D., The genetics of vertebrate myogenesis Nature Reviews Genetics 2008 9 8 632 646 (Pubitemid 352019755)
16. Biressi S., Molinaro M., Cossu G., Cellular heterogeneity during vertebrate skeletal muscle development Developmental Biology 2007 308 2 281 293 (Pubitemid 47223117)
17. Parker M. H., Seale P., Rudnicki M. A., Looking back to the embryo: defining transcriptional networks in adult myogenesis Nature Reviews Genetics 2003 4 7 497 507 (Pubitemid 36781341)
18. Sang L., Coller H. A., Roberts J. M., Control of the reversibility of cellular quiescence by the transcriptional repressor HES1 Science 2008 321 5892 1095 1100
19. Roma J., Masia A., Reventos J., Sanchez de Toledo J., Gallego S., A Human Protein with Sequence Similarity to Drosophila mastermind coordinates the nuclear form of notch and a CSL protein to build a transcriptional activator complex on target promoters Clinical Cancer Research 2011 17 505 513
20. Belyea B. C., Naini S., Bentley R. C., Linardic C. M., Inhibition of the notch-hey1 axis blocks embryonal rhabdomyosarcoma tumorigenesis Clinical Cancer Research 2011 17 23 7324 7336
21. Singh S., Vinson C., Gurley C. M., Nolen G. T., Beggs M. L., Nagarajan R., Wagner E. F., Parham D. M., Peterson C. A., Impaired Wnt signaling in embryonal rhabdomyosarcoma cells from p53/c-fos double mutant mice American Journal of Pathology 2010 177 4 2055 2066
22. Zeng F. Y., Dong H., Cui J., Liu L., Chen T., Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells Biochemical and Biophysical Research Communications 2010 391 1 1049 1055
23. Tostar U., Toftgrd R., Zaphiropoulos P. G., Shimokawa T., Reduction of human embryonal rhabdomyosarcoma tumor growth by inhibition of the hedgehog signaling pathway Genes and Cancer 2010 1 9 941 951
24. Gerber A. N., Wilson C. W., Li Y. J., Chuang P. T., The hedgehog regulated oncogenes Gli1 and Gli2 block myoblast differentiation by inhibiting MyoD-mediated transcriptional activation Oncogene 2007 26 8 1122 1136
25. Kopan R., Nye J. S., Weintraub H., The intracellular domain of mouse Notch: a constitutively activated repressor of myogenesis directed at the basic helix-loop-helix region of MyoD Development 1994 120 9 2385 2396 (Pubitemid 24268814)
26. Kuroda K., Tani S., Tamura K., Minoguchi S., Kurooka H., Honjo T., Delta-induced Notch signaling mediated by RBP-J inhibits MyoD expression and myogenesis The Journal of Biological Chemistry 1999 274 11 7238 7244
27. Buas M. F., Kabak S., Kadesch T., The notch effector Hey1 associates with myogenic target genes to repress myogenesis The Journal of Biological Chemistry 2010 285 2 1249 1258
28. Wilson-Rawls J., Molkentin J. D., Black B. L., Olson E. N., Activated Notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C Molecular and Cellular Biology 1999 19 4 2853 2862 (Pubitemid 29144529)
29. Conboy I. M., Rando T. A., The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis Developmental Cell 2002 3 3 397 409
30. Vasyutina E., Lenhard D. C., Wende H., Erdmann B., Epstein J. A., Birchmeier C., RBP-J (Rbpsuh) is essential to maintain muscle progenitor cells and to generate satellite cells Proceedings of the National Academy of Sciences of the United States of America 2007 104 11 4443 4448 (Pubitemid 47186245)
31. MacDonald B. T., Tamai K., He X., Wnt/ -Catenin signaling: components, mechanisms, and diseases Developmental Cell 2009 17 1 9 26
32. Clevers H., Wnt/ -catenin signaling in development and disease Cell 2006 127 3 469 480 (Pubitemid 44647433)
33. Brunelli S., Relaix F., Baesso S., Buckingham M., Cossu G., Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity Developmental Biology 2007 304 2 604 614 (Pubitemid 46527564)
34. Borello U., Berarducci B., Murphy P., Bajard L., Buffa V., Piccolo S., Buckingham M., Cossu G., The Wnt/ -catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis Development 2006 133 18 3723 3732 (Pubitemid 44614293)
35. Tajbakhsh S., Borello U., Vivarelli E., Kelly R., Papkoff J., Duprez D., Buckingham M., Cossu G., Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5 Development 1998 125 21 4155 4162 (Pubitemid 28528923)
36. Hutcheson D. A., Zhao J., Merrell A., Haldar M., Kardon G., Embryonic and fetal limb myogenic cells are derived from developmentally distinct progenitors and have different requirements for -catenin Genes and Development 2009 23 8 997 1013
37. Brack A. S., Conboy I. M., Conboy M. J., Shen J., Rando T. A., A temporal switch from notch to Wnt signaling in muscle stem cells is necessary for normal adult myogenesis Cell Stem Cell 2008 2 1 50 59
38. Polesskaya A., Seale P., Rudnicki M. A., Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration Cell 2003 113 7 841 852 (Pubitemid 36792029)
39. Descamps S., Arzouk H., Bacou F., Bernardi H., Fedon Y., Gay S., Reyne Y., Rossano B., Levin J., Inhibition of myoblast differentiation by Sfrp1 and Sfrp2 Cell and Tissue Research 2008 332 2 299 306
40. Brack A. S., Conboy M. J., Roy S., Lee M., Kuo C. J., Keller C., Rando T. A., Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis Science 2007 317 5839 807 810 (Pubitemid 47257918)
41. Armstrong D. D., Wong V. L., Esser K. A., Expression of -catenin is necessary for physiological growth of adult skeletal muscle American Journal of Physiology 2006 291 1 C185 C188
42. Otto A., Schmidt C., Luke G., Allen S., Valasek P., Muntoni F., Lawrence-Watt D., Patel K., Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration Journal of Cell Science 2008 121 17 2939 2950
43. Perez-Ruiz A., Ono Y., Gnocchi V. F., Zammit P. S., -catenin promotes self-renewal of skeletal-muscle satellite cells Journal of Cell Science 2008 121 9 1373 1382 (Pubitemid 351936302)
44. Zhao P., Hoffman E. P., Embryonic Myogenesis Pathways in Muscle Regeneration Developmental Dynamics 2004 229 2 380 392 (Pubitemid 38140478)
45. Ingham P. W., Nakano Y., Seger C., Mechanisms and functions of Hedgehog signalling across the metazoa Nature Reviews Genetics 2011 12 6 393 406
46. Lee J. J., Ekker S. C., Von Kessler D. P., Porter J. A., Sun B. I., Beachy P. A., Autoproteolysis in hedgehog protein biogenesis Science 1994 266 5190 1528 1537
47. Burke R., Nellen D., Bellotto M., Hafen E., Senti K. A., Dickson B. J., Basler K., Dispatched, a novel sterol-sensing domain protein dedicated to the release of cholesterol-modified Hedgehog from signaling cells Cell 1999 99 7 803 815 (Pubitemid 30017650)
48. Taipale J., Cooper M. K., Maiti T., Beachy P. A., Patched acts catalytically to suppress the activity of smoothened Nature 2002 418 6900 892 897 (Pubitemid 34966310)
49. Tukachinsky H., Lopez L. V., Salic A., A mechanism for vertebrate Hedgehog signaling: recruitment to cilia and dissociation of SuFu-Gli protein complexes Journal of Cell Biology 2010 191 2 415 428
50. Sasaki H., Nishizaki Y., Hui C. C., Nakafuku M., Kondoh H., Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling Development 1999 126 17 3915 3924 (Pubitemid 29440488)
51. Gustafsson M. K., Pan H., Pinney D. F., Liu Y., Lewandowski A., Epstein D. J., Emerson C. P., Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification Genes and Development 2002 16 1 114 126 (Pubitemid 34049642)
52. Krger M., Mennerich D., Fees S., Schfer R., Mundlos S., Braun T., Sonic hedgehog is a survival factor for hypaxial muscles during mouse development Development 2001 128 5 743 752 (Pubitemid 32229251)
53. Straface G., Aprahamian T., Flex A., Gaetani E., Biscetti F., Smith R. C., Pecorini G., Pola E., Angelini F., Stigliano E., Castellot J. J., Losordo D. W., Pola R., Sonic hedgehog regulates angiogenesis and myogenesis during post-natal skeletal muscle regeneration Journal of Cellular and Molecular Medicine 2009 13 8 2424 2435
54. Koleva M., Kappler R., Vogler M., Herwig A., Fulda S., Hahn H., Pleiotropic effects of sonic hedgehog on muscle satellite cells Cellular and Molecular Life Sciences 2005 62 16 1863 1870 (Pubitemid 41188525)
55. Bren-Mattison Y., Olwin B. B., Sonic hedgehog inhibits the terminal differentiation of limb myoblasts committed to the slow muscle lineage Developmental Biology 2002 242 2 130 148 (Pubitemid 34163976)
56. Mill P., Mo R., Hu M. C., Dagnino L., Rosenblum N. D., Hui C. C., Shh controls epithelial proliferation via independent pathways that converge on N-Myc Developmental Cell 2005 9 2 293 303 (Pubitemid 41051747)
57. Walter D., Satheesha S., Albrecht P., Bornhauser B. C., D'Alessandro V., Oesch S. M., Rehrauer H., Leuschner I., Koscielniak E., Gengler C., Moch H., Bernasconi M., Niggli F. K., Schfer B. W., CD133 positive embryonal rhabdomyosarcoma stem-like cell population is enriched in rhabdospheres PLoS ONE 2011 6 5, article e19506
58. Powell S. M., Zilz N., Beazer-Barclay Y., Bryan T. M., Hamilton S. R., Thibodeau S. N., Vogelstein B., Kinzler K. W., APC mutations occur early during colorectal tumorigenesis Nature 1992 359 6392 235 237
59. Wang Z., Smith K. S., Murphy M., Piloto O., Somervaille T. C. P., Cleary M. L., Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy Nature 2008 455 7217 1205 1209
60. Ougolkov A. V., Fernandez-Zapico M. E., Savoy D. N., Urrutia R. A., Billadeau D. D., Glycogen synthase kinase-3 participates in nuclear factor B-mediated gene transcription and cell survival in pancreatic cancer cells Cancer Research 2005 65 6 2076 2081 (Pubitemid 40490111)
61. Tan J., Zhuang L., Leong H. S., Iyer N. G., Liu E. T., Yu Q., Pharmacologic modulation of glycogen synthase kinase-3 promotes p53-dependent apoptosis through a direct bax-mediated mitochondrial pathway in colorectal cancer cells Cancer Research 2005 65 19 9012 9020 (Pubitemid 41377393)
62. Hirata H., Hinoda Y., Ueno K., Majid S., Saini S., Dahiya R., Role of secreted frizzled-related protein 3 in human renal cell carcinoma Cancer Research 2010 70 5 1896 1905
63. Soglio D. B. D., Rougemont A. L., Absi R., Giroux L. M., Sanchez R., Barrette S., Fournet J. C., Beta-catenin mutation does not seem to have an effect on the tumorigenesis of pediatric rhabdomyosarcomas Pediatric and Developmental Pathology 2009 12 5 371 373
64. Ng T. L., Gown A. M., Barry T. S., Cheang M. C. U., Chan A. K. W., Turbin D. A., Hsu F. D., West R. B., Nielsen T. O., Nuclear beta-catenin in mesenchymal tumors Modern Pathology 2005 18 1 68 74 (Pubitemid 40128097)
65. Fredericks W. J., Ayyanathan K., Herlyn M., Friedman J. R., Rauscher F. J. III, An engineered PAX3-KRAB transcriptional repressor inhibits the malignant phenotype of alveolar rhabdomyosarcoma cells harboring the endogenous PAX3- FKHR oncogene Molecular and Cellular Biology 2000 20 14 5019 5031 (Pubitemid 30431556)
66. Gorlin R. J., Nevoid basal cell carcinoma (Gorlin) syndrome: unanswered issues Journal of Laboratory and Clinical Medicine 1999 134 6 551 552
67. Hahn H., Wojnowski L., Zimmer A. M., Hall J., Miller G., Zimmer A., Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome Nature Medicine 1998 4 5 619 622 (Pubitemid 28237364)
68. Hahn H., Nitzki F., Schorban T., Hemmerlein B., Threadgill D., Rosemann M., Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2 Genomics 2004 84 5 853 858 (Pubitemid 39314445)
69. Calzada-Wack J., Schnitzbauer U., Walch A., Wurster K. H., Kappler R., Nathrath M., Hahn H., Analysis of the PTCH coding region in human rhabdomyosarcoma Human mutation 2002 20 3 233 234
70. Bridge J. A., Liu J., Weibolt V., Baker K. S., Perry D., Kruger R., Qualman S., Barr F., Sorensen P., Triche T., Suijkerbuijk R., Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study Genes Chromosomes and Cancer 2000 27 4 337 344 (Pubitemid 30127620)
71. Tostar U., Malm C. J., Meis-Kindblom J. M., Kindblom L. G., Toftgrd R., Undén A. B., Deregulation of the hedgehog signalling pathway: a possible role for the PTCH and SUFU genes in human rhabdomyoma and rhabdomyosarcoma development Journal of Pathology 2006 208 1 17 25 (Pubitemid 43025700)
72. Hahn H., Wojnowski L., Zimmer A. M., Hall J., Miller G., Zimmer A., Rhabdomyosarcomas and radiation hypersensitivity in a mouse model of Gorlin syndrome Nature Medicine 1998 4 5 619 622 (Pubitemid 28237364)
73. LoRusso P. M., Rudin C. M., Reddy J. C., Tibes R., Weiss G. J., Borad M. J., Hann C. L., Brahmer J. R., Chang I., Darbonne W. C., Graham R. A., Zerivitz K. L., Low J. A., Von Hoff D. D., Phase I trial of hedgehog pathway inhibitor vismodegib (GDC-0449) in patients with refractory, locally advanced or metastatic solid tumors Clinical Cancer Research 2011 17 8 2502 2511
74. Ecke I., Rosenberger A., Obenauer S., Dullin C., Aberger F., Kimmina S., Schweyer S., Hahn H., Cyclopamine treatment of full-blown Hh/Ptch-associated RMS partially inhibits Hh/Ptch signaling, but not tumor growth Molecular Carcinogenesis 2008 47 5 361 372 (Pubitemid 351614576)
75. Rubin B. P., Nishijo K., Chen H. I. H., Yi X., Schuetze D. P., Pal R., Prajapati S. I., Abraham J., Arenkiel B. R., Chen Q. R., Davis S., McCleish A. T., Capecchi M. R., Michalek J. E., Zarzabal L. A., Khan J., Yu Z., Parham D. M., Barr F. G., Meltzer P. S., Chen Y., Keller C., Evidence for an unanticipated relationship between undifferentiated pleomorphic sarcoma and embryonal rhabdomyosarcoma Cancer Cell 2011 19 2 177 191
76. Pressey J. G., Anderson J. R., Crossman D. K., Lynch J. C., Barr F. G., Hedgehog pathway activity in pediatric embryonal rhabdomyosarcoma and undifferentiated sarcoma: a report from the Children's Oncology Group Pediatric Blood and Cancer 2011 57 6 930 938
77. Purow B., Notch inhibitors as a new tool in the war on cancer: a pathway to watch Current Pharmaceutical Biotechnology 2009 10 2 154 160
78. Luistro L., He W., Smith M., Packman K., Vilenchik M., Carvajal D., Roberts J., Cai J., Berkofsky-Fessler W., Hilton H., Linn M., Flohr A., Jakob-Rtne R., Jacobsen H., Glenn K., Heimbrook D., Boylan J. F., Preclinical profile of a potent -secretase inhibitor targeting notch signaling with in vivo efficacy and pharmacodynamic properties Cancer Research 2009 69 19 7672 7680
79. Moellering R. E., Cornejo M., Davis T. N., Bianco C. D., Aster J. C., Blacklow S. C., Kung A. L., Gilliland D. G., Verdine G. L., Bradner J. E., Direct inhibition of the Notch transcription factor complex Nature 2009 462 7270 182 188
80. Barker N., Clevers H., Mining the Wnt pathway for cancer therapeutics Nature Reviews Drug Discovery 2006 5 12 997 1014 (Pubitemid 44835127)
81. Watanabe K., Dai X., Winning WNT: race to Wnt signaling inhibitors Proceedings of the National Academy of Sciences of the United States of America 2011 108 15 5929 5930
82. Huang S. M. A., Mishina Y. M., Liu S., Cheung A., Stegmeier F., Michaud G. A., Charlat O., Wiellette E., Zhang Y., Wiessner S., Hild M., Shi X., Wilson C. J., Mickanin C., Myer V., Fazal A., Tomlinson R., Serluca F., Shao W., Cheng H., Shultz M., Rau C., Schirle M., Schlegl J., Ghidelli S., Fawell S., Lu C., Curtis D., Kirschner M. W., Lengauer C., Finan P. M., Tallarico J. A., Bouwmeester T., Porter J. A., Bauer A., Cong F., Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling Nature 2009 461 7264 614 620
83. Gonsalves F. C., Klein K., Carson B. B., Katz S., Ekas L. A., Evans S., Nagourney R., Cardozo T., Brown A. M.C., Das Gupta R., An RNAi-based chemical genetic screen identifies three small-molecule inhibitors of the Wnt/wingless signaling pathway Proceedings of the National Academy of Sciences of the United States of America 2011 108 15 5954 5963
84. Klein P. S., Melton D. A., A molecular mechanism for the effect of lithium on development Proceedings of the National Academy of Sciences of the United States of America 1996 93 16 8455 8459 (Pubitemid 26269579)
85. Thomas T., Stansifer L., Findling R. L., Psychopharmacology of pediatric bipolar disorders in children and adolescents Pediatric Clinics of North America 2011 58 1 173 187
86. Newport D. J., Viguera A. C., Beach A. J., Ritchie J. C., Cohen L. S., Stowe Z. N., Lithium placental passage and obstetrical outcome: implications for clinical management during late pregnancy American Journal of Psychiatry 2005 162 11 2162 2170 (Pubitemid 41598272)
87. Pearlstein T., Perinatal depression: treatment options and dilemmas Journal of Psychiatry and Neuroscience 2008 33 4 302 318 (Pubitemid 351977157)
88. Lubner S. J., Kunnimalaiyaan M., Holen K. D., Ning L., Ndiaye M., Loconte N. K., Mulkerin D. L., Schelman W. R., Chen H., A preclinical and clinical study of lithium in low-grade neuroendocrine tumors Oncologist 2011 16 4 452 457
89. Coghlan M. P., Culbert A. A., Cross D. A. E., Corcoran S. L., Yates J. W., Pearce N. J., Rausch O. L., Murphy G. J., Carter P. S., Roxbee Cox L., Mills D., Brown M. J., Haigh D., Ward R. W., Smith D. G., Murray K. J., Reith A. D., Holder J. C., Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription Chemistry and Biology 2000 7 10 793 803
90. Park E. J., Choi S. J., Kim Y. C., Lee S. H., Park S. W., Lee S. K., Novel small molecule activators of -catenin-mediated signaling pathway: structure-activity relationships of indirubins Bioorganic and Medicinal Chemistry Letters 2009 19 8 2282 2284
91. Bodine P. V. N., Stauffer B., Ponce-de-Leon H., Bhat R. A., Mangine A., Seestaller-Wehr L. M., Moran R. A., Billiard J., Fukayama S., Komm B. S., Pitts K., Krishnamurthy G., Gopalsamy A., Shi M., Kern J. C., Commons T. J., Woodworth R. P., Wilson M. A., Welmaker G. S., Trybulski E. J., Moore W. J., A small molecule inhibitor of the Wnt antagonist secreted frizzled-related protein-1 stimulates bone formation Bone 2009 44 6 1063 1068
92. Chen J. K., Taipale J., Young K. E., Maiti T., Beachy P. A., Small molecule modulation of smoothened activity Proceedings of the National Academy of Sciences of the United States of America 2002 99 22 14071 14076 (Pubitemid 35257626)
93. Von Hoff D. D., LoRusso P. M., Rudin C. M., Reddy J. C., Yauch R. L., Tibes R., Weiss G. J., Borad M. J., Hann C. L., Brahmer J. R., Mackey H. M., Lum B. L., Darbonne W. C., Marsters J. C., De Sauvage F. J., Low J. A., Inhibition of the hedgehog pathway in advanced basal-cell carcinoma The New England Journal of Medicine 2009 361 12 1164 1172
94. Klingebiel T., Boos J., Beske F., Hallmen E., Int-Veen C., Dantonello T., Treuner J., Gadner H., Marky I., Kazanowska B., Koscielniak E., Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial Pediatric Blood and Cancer 2008 50 4 739 745 (Pubitemid 351354776)